{
  "source_file": "/content/drive/MyDrive/disorders/Schizophrenia_Spectrum_out/SubSection7_Substance_Medication_Induced_Psychotic_Disorder.txt",
  "original_path": "Schizophrenia_Spectrum_out/SubSection7_Substance_Medication_Induced_Psychotic_Disorder.txt",
  "model": "text-embedding-3-large",
  "dimension": 3072,
  "chunks": [
    {
      "id": 0,
      "text_preview": "Substance/Medication-Induced Psychotic Disorder Diagnostic Criteria A. Presence of one or both of the following symptoms: 1. Delusions. 2. Hallucinations. B. There is evidence from the history, physic...",
      "word_count": 1000
    },
    {
      "id": 1,
      "text_preview": "should be listed separately (e.g., F12.259 severe cannabis use disorder with cannabis-induced psychotic disorder, with onset during intoxication; F16.159 mild phencyclidine use disorder with phencycli...",
      "word_count": 1000
    },
    {
      "id": 2,
      "text_preview": "the highest rate (44%) for cannabis-induced psychotic disorder. 130 Diagnostic Markers With substances for which relevant blood levels are available (e.g., blood alcohol level, other quantifiable bloo...",
      "word_count": 545
    }
  ],
  "html_page": "Schizophrenia_Spectrum_out/Substance_Medication_Induced_Psychotic_Disorder.html"
}